Hexarelin
Also known as: Examorelin, Hexarelin acetate, GHRP hexapeptide
Classification
Peptide
Regulatory Status
not-established
Sources
12
Review
n/a
Overview
Hexarelin is a synthetic hexapeptide GHRP-class growth hormone secretagogue that stimulates growth hormone release both in vitro and in vivo by acting as a ghrelin/growth hormone secretagogue receptor (GHS-R1a) agonist.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Hexarelin is a synthetic hexapeptide GHRP-class growth hormone secretagogue that stimulates growth hormone release both in vitro and in vivo by acting as a ghrelin/growth hormone secretagogue receptor (GHS-R1a) agonist.
Interactions & cautions
Drug interactions
other growth hormone secretagogues or recombinant GH — Unpredictable IGF-1 elevation and monitoring burden (review)
These are observational flags for review, not individualized instructions.
Sources
- https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks (opens in a new tab)
- https://www.drugs.com/wada/s2-peptide-hormones-growth-factors-and-related-substances.html
- https://pubmed.ncbi.nlm.nih.gov/7957536/ (opens in a new tab)
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw